EVERGLADES BIOPHARMA LLC — Federal Contracts, Awards & Government Contractor Profile

About EVERGLADES BIOPHARMA LLC

Everglades Biopharma is a leader in developing ligand-based therapies using proprietary ligandomics technology to identify disease-specific cellular ligands as therapeutic targets. A key product is a therapeutic antibody targeting a novel angiogenic ligand for conditions such as AMD, diabetic macular edema, and cancer.

Development of ligand-based therapiesProprietary ligandomics technology for identifying disease-specific cellular ligandsRational development of therapies by overexpressing or blocking specific ligandsTherapeutic antibody development for neovascular diseases

Is this your company?

Claim EVERGLADES BIOPHARMA LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim EVERGLADES BIOPHARMA LLC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.